Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial
Publication
, Conference
Yan, AT; Yan, RT; Tan, M; Armstrong, PW; Granger, CB; Dabbous, O; Fox, KAA; Eagle, KA; Huynh, T; Fitchett, DH; Langer, A; Goodman, SG
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2005
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
2005
Volume
45
Issue
3
Start / End Page
230A / 230A
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Yan, A. T., Yan, R. T., Tan, M., Armstrong, P. W., Granger, C. B., Dabbous, O., … Goodman, S. G. (2005). Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 45, pp. 230A-230A).
Yan, A. T., R. T. Yan, M. Tan, P. W. Armstrong, C. B. Granger, O. Dabbous, K. A. A. Fox, et al. “Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45:230A-230A, 2005.
Yan AT, Yan RT, Tan M, Armstrong PW, Granger CB, Dabbous O, et al. Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005. p. 230A-230A.
Yan, A. T., et al. “Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 45, no. 3, 2005, pp. 230A-230A.
Yan AT, Yan RT, Tan M, Armstrong PW, Granger CB, Dabbous O, Fox KAA, Eagle KA, Huynh T, Fitchett DH, Langer A, Goodman SG. Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005. p. 230A-230A.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
2005
Volume
45
Issue
3
Start / End Page
230A / 230A
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology